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ERK Involvement in Resistance to Apoptosis in
Keratinocytes with Mutant Keratin
David Russell1, Heike Ross1,3 and E Birgitte Lane1,2
The consequences of cell stress induced by misfolded proteins are an important contributor to many human
diseases. One such disease is epidermolysis bullosa simplex (EBS), caused by mutations in the structural proteins
(keratins K5 or K14) of the proliferative compartment of the epidermis (basal keratinocyte layer), leading to cell fragility
and blistering. In severe EBS, the mutation is associated with aggregates of nonfilamentous keratin protein, and cell
lines carrying such mutations show a constitutively activated stress response. Analysis of the cellular mechanisms
leading to cell breakdown on physical stress may point the way to mutation-independent therapeutic approaches to
these incurable genetic disorders. We therefore subjected EBS cell lines, immortalized from patients with EBS, to an
oscillating mechanical stress in assays designed to mimic the physical trauma that leads to cell breakdown in vivo.
These experiments show that mechanical stress activates extracellular signal-regulated kinase (ERK) signaling in these
cells, and that the keratin mutant cells also show a resistance to apoptosis following mechanical stress that is reversed
by inhibiting ERK. The consequences of constitutive expression of large amounts of defective structural protein in a
tissue cell must be properly understood for the development of safe and effective therapies for these disorders.
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INTRODUCTION
The epidermis of the outer layer of the skin operates two very
different forms of programmed cell death taking place in close
proximity. Most programmed cell death in the epidermis takes
the form of a modified type of apoptosis in which dead cells are
retained—not engulfed and cleared—and form the functional
barrier with the external environment. A smaller fraction of con-
ventional apoptosis functions in removing cells with damaged
DNA (Liu et al., 1994) or remodeling tissue shape, such as
during resolution of transient overgrowth during regression of
psoriatic plaques (Laporte et al., 2000; Heenen and Simonart,
2008). Thus, epidermal keratinocytes are capable of main-
taining a well-regulated balance between these two related
processes, the delayed and attenuated apoptosis in the upper
cell layers versus the conventional apoptosis in the lower
undifferentiated cells, to protect the tissue from damage. Control
of the interface between these processes is not understood.
The epidermis is subjected to repeated substantial
mechanical stress, which results in activation of stress
response signaling pathways but does not normally lead to
apoptosis. In some pathological conditions, mutations in
cytoskeleton proteins render the cells less able to resist
mechanical stress, resulting in physical damage to the tissue.
Although this might be predicted to lead to apoptosis in an
acute situation, the genetic nature of this pathology means
that the damage is chronic and extensive apoptotic clearing
could be deleterious to the sustaining of skin barrier function.
Epidermolysis bullosa simplex (EBS) is one such disorder
caused by a mutation in the basal cells, keratins K5 and K14.
The undifferentiated and proliferative basal keratinocytes
carrying severe EBS mutations are susceptible to rupture when
the skin is subjected to even quite mild physical trauma (Bonifas
et al., 1991; Coulombe et al., 1991; Lane et al., 1992). We
examined the response to mechanical stress of cells expressing a
keratin mutation associated with a severe form of skin fragility,
Dowling-Meara type EBS (DM-EBS). In this study we demon-
strate that under conditions of mechanical stress, the DM-EBS
cells show greater resistance to conventional apoptosis than
their wild-type keratin counterparts. This increased resistance
appears to be specifically dependant on (i) the presence of the
mutant keratin and (ii) an increase in ERK and Akt signaling in
these cells. The fact that the presence of a keratin mutation can
lead to changes in the apoptosis machinery in cells provides yet
further evidence that the function of intermediate filaments is
not purely to provide mechanical stability to cells.
RESULTS
Apoptosis is delayed and reduced in cells carrying a severe
pathogenic keratin mutation
During the development of a mechanical stretch assay, cells
were examined to determine whether the stretch parameters
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induced apoptosis. Two hours of oscillating mechanical
stretch increased apoptosis in both control and disease-
mutant cell lines (Figure 1a). Wild-type keratinocytes (NEB-1)
were more susceptible to apoptosis than keratinocytes
carrying a severe EBS-associated mutation (KEB-7). Under
resting conditions, both NEB-1 and KEB-7 cells exhibit similar
numbers of apoptotic cells. We therefore treated cells with
etoposide, to determine whether the reduced apoptosis in
KEB-7 cells (Figure 1a) was a specific response to mechanical
stretch. Cells were cultured in the presence and absence of
10 mM etoposide for 24 and 48 hours (Figure 1b). Although
etoposide treatment significantly increased apoptosis in both
cell lines, after 24 hours treatment the DM-EBS (KEB-7) cells
have approximately 20% less apoptotic cells than the wild-
type (NEB-1) cells and 10% less after 48 hours treatment
(Figure 1b). This is a similar pattern to that observed for
mechanical stretch and suggests that the apoptotic response is
generically suppressed in KEB-7 cells.
Yoneda et al. (2004) transiently transfected a construct
expressing the K14-R125C mutation and showed that
48 hours after transfection there was an increased suscept-
ibility to apoptosis. A significant difference between this and
the present study, however, is that our study used patient-
derived stable cell lines.
To assess the impact of transfection per se on apoptosis,
we determined the number of apoptotic cells 48 hours after
transfection with a range of constructs (Figure 2). Using
electroporation and a liposome-based reagent, we found an
increase in apoptotic cell numbers using both methods in all
three cell lines tested, with apoptosis consistently higher
when using the liposome-based reagent (Figure 2a). We have
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Figure 1. DM-EBS (KEB-7) keratinocytes show delayed and reduced
apoptosis in response to etoposide treatment and mechanical stretch.
DM-EBS (KEB-7) and control (NEB-1) keratinocytes were treated with 10 mM
etoposide (a) or subjected to 2 hours mechanical stretch (b). Cells were
4,6-diamidino-2-phenylindole stained, and 100 cells were counted and scored
for the appearance of apoptotic nuclei. This was repeated three times, and the
average percentage of apoptotic cells was plotted. Cells were examined before
stretch or etoposide treatment, 24hours after a 2-hour stretch or etoposide
treatment, and 48hours after a 2-hour stretch or etoposide treatment. Error bars
represent s.d. NS, no stretch; Rec, recovery; Str, stretch.
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Figure 2. Transfection liposomes results in more apoptotic cells than
transfection by electroporation. Dowling-Meara type epidermolysis bullosa
simplex (DM-EBS) (KEB-7), control (NEB-1), and HaCaT keratinocytes were
transfected with constructs driving expression of K5-GFP, K14R125P-GFP,
and Tubulin-GFP. An empty pEGFP-C1 construct was used as a control as was
mock transfection. Transfection of these constructs was achieved using a
liposome-based method (Lipofectamine 2000) (a) and electroporation (b).
After 48 hours transfection, cells were 4,6-diamidino-2-phenylindole stained
and 100 cells counted and scored for the appearance of apoptotic nuclei. This
was repeated three times and the average percentage of apoptotic cells was
plotted. Error bars represent SD.
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observed that transfection of even a wild-type keratin
frequently results in keratin aggregation in the short term,
although this resolves with time (our unpublished observa-
tions). The different apoptotic response in patient-derived
versus transfected cells may reflect a difference in the
response to sudden acute protein accumulation (transient
transfection) and chronic long-term protein aggregation
(patient-derived cells).
DM-EBS keratinocytes have a constitutively active ERK
signaling pathway
Cell stress is detected through the mitogen-activated protein
kinase (MAPK) signal-transduction pathways. There are three
core MAPK cascades: SAPK/JNK (from various stress signals
and inflammatory cytokines), p38 MAPK (also mostly acute
and toxic stresses), or ERK 1/2 (predominantly through growth
signals).
As the presence of a DM-EBS mutation leads to reduced
apoptosis in response to stress, we examined ERK signaling as
it is involved in the general control of growth and
proliferation of cells, and as recently suggested, possibly also
apoptosis (Perlson et al., 2006; Kumar et al., 2007). As ERK
signaling is increased in the presence of growth factors
(Brunet et al., 1994), we used serum starvation to assess the
level of ERK signaling under resting conditions and in
response to stretch (Figure 3). Serum removal reduced
MEK1/2 phosphorylation in NEB-1 cells but had little effect
in KEB-7 cells (Figure 3a, lanes 1 and 2). This difference was
also seen for other components of the ERK pathway. Most
dramatically, phosphorylation of p90RSK, a direct down-
stream target of ERK1/2, was undetectable in the serum-
starved wild-type NEB-1 cells, whereas in KEB-7 cells serum
removal had no effect on p90RSK phosphorylation (Figure 3c,
lanes 1 and 2).
This experiment showed that ERK signaling in KEB-7 cells is
resistant to serum starvation and suggests that ERK activation is
not due to stimulatory signals derived from serum, although we
cannot exclude activation through autocrine signaling. The
stretch assay was designed to try to reproduce the epidermal
damage that occurs in EBS sufferers (Russell et al., 2004).
Therefore, further experiments were carried out in the
presence of serum, as in a damaged epidermis there is
naturally an increase in the local concentration of growth
factors and hormones as tissue repair begins.
Mechanical stress increases ERK pathway MAPK signaling in
keratinocytes
We examined the ERK signaling pathway in response to
oscillating mechanical stretch (Figure 3). Ten minutes after
commencing stretch, both normal (NEB-1) and EBS (KEB-7)
cell lines show a decrease in phosphorylation of MEK1/2
(Figure 3a, compare lanes 2 and 3). By 30minutes of stretch,
phosphorylation of MEK1/2 had decreased in NEB-1 cells and
phosphorylation levels remained constant as long as the
stretch cycling continued (Figure 3a, lanes 4–6). KEB-7 cells
responded differently: after a further slight decrease at
30minutes, phosphorylation levels then rose and continued
to increase with time of stretch (Figure 3a, lanes 4–6).
Phosphorylation of ERK1/2 (p42/44 MAPK) decreased in
NEB-1 cells as mechanical stress was initiated (Figure 3b) and
remained low for the duration of the stress. KEB-7 cells
showed noticeably reduced ERK1/2 phosphorylation by
10minutes of stretch (Figure 3b, compare lanes 2 and 3). In
KEB-7 cells, p42 phosphorylation remained low and p44
phosphorylation increased with time of stretch. NEB-1 and
KEB-7 cells show a decrease in p90RSK phosphorylation after
30minutes (Figure 3c, lane 4), with a second peak between
60 and 120minutes in NEB-1 cells (Figure 3c, lane 5).
However, unlike the control cells, p90RSK phosphorylation
in KEB-7 cells continued to rise with time of stretch.
This experiment shows that the ERK pathway components
show a surge of phosphorylation on mechanical stress,
dropping to a minimum phosphorylation at 30minutes.
Thereafter, phosphorylation levels in KEB-7 cells increased
with time, whereas in NEB-1 cells ERK pathway phosphor-
ylation remained at low levels. Using hypo-osmotic shock,
we recently demonstrated a stress-induced increase in JNK
signaling (D’Alessandro et al., 2002), p38 and ERK1/2 (Liovic
et al., 2008) in these same cell lines. Signaling through these
pathways may provide a life-or-death balance and it is
possible that in our system ERK signaling is reduced as cells
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Figure 3. The ERK pathway signaling is increased in Dowling-Meara type
epidermolysis bullosa simplex (DM-EBS) (KEB-7) keratinocytes. Cell lysates
were prepared from cultured keratinocytes, 10mg lysate was separated by
SDS–PAGE and immunoblotted with antibodies against phospho-MEK1/2 (a),
phospho-p42/44 MAPK (b), phospho-p90RSK (c), and MEK1/2 (d). Lanes 1
and 2 are from the same blot as lanes 3–7 but have been separated for ease of
description.
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deal with the initial stress imposed here by stretch through
activation of other signaling pathways.
PKB/Akt and PKA phosphorylation is elevated in KEB-7 cells
ERK signaling promotes cell survival by inhibiting the
proapoptotic protein BAD (Bonni et al., 1999). This inhibition
requires phosphorylation of BAD. This occurs at serine 112
by p90RSK (Bonni et al., 1999) and protein kinase A (PKA)
(Jin et al., 2004). PKA also phosphorylates BAD at serine 155
(Lizcano et al., 2000) and PKB/Akt phosphorylates BAD at
serine 136 (Tan et al., 2000). We therefore examined the
activation status of Akt and PKA in response to stretch
(Figure 4). The time course of analysis was extended beyond
24 hours to cover the period when apoptosis is most likely to
be observed. Phosphorylation was examined immediately
after 2 hours of stretch and then at 24 and 48 hours of
recovery from a 2-hours stretch.
NEB-1 cells had barely detectable Akt-Thr308 phosphor-
ylation at all time points examined (Figure 4a, i) and this was
also the case for Akt-Ser473 phosphorylation (Figure 4a, ii).
KEB-7 mutant keratin cells, however, exhibit detectable
phosphorylation of Akt at both threonine 308 (Figure 4a, i)
and serine 473 (Figure 4a, ii). Phosphorylation at threonine
308 was unchanged after 2 hours of stretch but decreased
from 24 to 48 hours after mechanical stress (Figure 4a, i). Two
hours of stretching resulted in a slight increase in Akt
phosphorylation at serine 473 in KEB-7 cells, followed
by a decrease at 24 hours after stretch and no detectable
phosphorylation by 48 hours after cessation of stretch
(Figure 4a, ii).
Protein kinase A phosphorylation was constitutively active
in KEB-7 cells with high levels of phosphorylation at all time
points (Figure 4b, i). In NEB-1 cells, there was evidence of
PKA phosphorylation before stretch, with an increase in
phosphorylation after 2 hours of stretch, continuing to rise
during recovery from 24 to 48 hours (Figure 4b, i).
BAD dephosphorylation is delayed in KEB-7 cells in response to
stretch
The increased p90RSK, Akt, and PKA activation in KEB-7
cells suggests that there should also be increased BAD
phosphorylation that should lead to reduced apoptosis in
KEB-7 cells. To test this, we examined BAD phosphorylation
before stretch; after stretch; and during recovery from stretch.
Both NEB-1 and KEB-7 have detectable phosphorylation at
all three BAD phosphorylation sites (Figure 5a, i–iii), although
serine 155 phosphorylation is barely detectable in NEB-1
cells (Figure 5a, iii). After stretch, and during recover from
stretch, both cell lines show a decrease in BAD phosphoryla-
tion levels but the reduction is much less pronounced in KEB-
7 cells. This shows that in KEB-7 cells, BAD phosphorylation
is increased and its dephosphorylation is delayed. Depho-
sphorylated BAD localizes to mitochondria where it interacts
with BcL-XL, suppressing the protective effect of BcL-XL and
promoting apoptosis. As protein phosphatase 2B (calcineurin)
has been shown to dephosphorylate BAD at serine 155
(Wang et al., 1999), we examined the association between
BAD and PP2B using immunoprecipitation (Figure 5b, i). A
lower level of association was found in KEB-7 cells compared
with NEB-1 cells. No significant change in BAD/PP2B
association was found in NEB-1 cells after or during recovery
from stretch. In KEB-7 cells, the association increased after
stretch and continued to increase during recovery from
stretch (Figure 5b, i).
This greater association in NEB-1 cells suggests that the
lower BAD-Ser155 phosphorylation may be due to depho-
sphorylation by PP2B. The lower levels of BAD/PP2B
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Figure 4. Differences in Akt and PKA signaling in NEB-1 and KEB-7 cells in
response to 2 hours mechanical stretching and recovery from stretch. Cell
lysates were prepared from cultured keratinocytes, 10 mg lysate was separated
by SDS–PAGE and immunoblotted with antibodies against phospho-Akt (Thr
308) (a, i), phospho-Akt (Ser 473) (a, ii), Akt (a, iii), phospho-PKA (b, i), and
PKA (b, ii). Cells were examined for these pathway components before stretch
(0 hours), immediately after 2 hours of stretch (2 hours), and 24 and 48hours
after 2 hours of stretch (24 and 48hours recovery).
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association in KEB-7 cells coupled with higher levels of
BAD-Ser155 phosphorylation (Figure 5a, iii), supports this
observation.
KEB-7 cells show increased BAD/14-3-3 and reduced
BAD/BcL-XL associations
Phosphorylated BAD interacts with 14-3-3 proteins
(Bonnefoy-Berard et al., 1995; Craparo et al., 1997;
Furlanetto et al., 1997), which sequesters BAD away from
mitochondria and prevent BAD from interacting with the
proapoptotic protein BcL-XL (Zha et al., 1996; Datta et al.,
2000; Bergmann, 2002). We examined BAD’s interaction
with these proteins using immunoprecipitation (Figure 6). As
apoptosis levels are low under normal conditions in these
cells, it was not unexpected to find BAD/14-3-3 association
in both cell lines in the absence of mechanical stretch
(Figure 6a). There was significantly less BAD/BcL-XL
association in KEB-7 cells, compared with NEB-1, before
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Figure 5. BAD phosphorylation is increased in DM-EBS (KEB-7)
keratinocytes in response to mechanical stretch. Cell lysates were
prepared from cultured keratinocytes, 10 mg lysate was separated by
SDS–PAGE and immunoblotted with antibodies against phospho-BAD
(Ser 112) (a, i), phospho-BAD (Ser 136) (a, ii), phospho-BAD (Ser155) (a, iii),
BAD (a, iv). Lysates from a 10-cm culture dish or a well from a flexplate
were lysed and immunoprecipitated using antibodies against BAD (b, i)
or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (b, ii). Cells were
examined for these pathway components before stretch (0 hours),
immediately after 2 hours of stretch (2 hours), and 24 and 48 hours after
2 hours of stretch (24 and 48hours recovery).
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Figure 6. DM-EBS keratinocytes (KEB-7) show greater association
between 14-3-3 and BcL-XL with BAD during recovery from stretch.
Lysates from a 10-cm culture dish or a well from a flexplate were lysed
and immunoprecipitated using antibodies against BAD or glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). Immunoprecipitates were subjected
to SDS polyacrylamide gel electrophoresis and immunoblotted with antibodies
against 14-3-3 (a), BcL-XL (b), and BAD (c). GAPDH Immunoprecipitates
were probed with GAPDH antibody to check for equal loading (d). Cells were
examined for these pathway components before stretch (0 hours),
immediately after 2 hours of stretch (2 hours) and 24 and 48hours after 2 hours
of stretch (24 and 48hours recovery).
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stretch (Figure 6b). This suggests that the apoptosis-survival
balance is already skewed toward cell survival in KEB-7 cells.
The level of BAD/BcL-XL association in KEB-7 increases
during recovery from stretch, presumably as cells enter
apoptosis. This increase is matched by a decrease in BAD/14-
3-3 association during recovery from stretch. The delayed
reduction of BAD/14-3-3 and delayed increase in BAD/
BcL-XL association in KEB-7 cells supports the observation
that the apoptosis pathway is suppressed in KEB-7 cells
compared with NEB-1 cells.
ERK signaling in KEB-7 cells is insensitive to serum removal but
sensitive to U0126 treatment
As the DM-EBS (KEB-7) cells used in this study have
constitutively active ERK signaling (Figure 3), we examined
the effect of the MEK1/2 inhibitor, U0126. U0126 prevents
MEK1/2 from phosphorylating its downstream target, p42/44
MAPK (Favata et al., 1998). Cells were treated with 5 mM
U0126 for 2 hours in the presence or absence of serum.
Serum removal alone reduced p42/44 and p90RSK phos-
phorylation in NEB-1 cells and this was also the case when
NEB-1 cells were treated with U0126 in the presence or
absence of serum (Figure 7a and b).
In KEB-7 cells, U0126 treatment reduces phosphorylation
of p42/44 MAPK and p90RSK in either the presence or
absence of serum. As shown previously (Figure 3), serum
removal alone does not reduce p42/44 and p90RSK
phosphorylation in KEB-7 cells and suggests that ERK
signaling in KEB-7 cells is activated through a route other
than from growth factors in serum.
Blocking ERK activation partially restores apoptosis rate in
KEB-7 cells toward wild-type levels
Caspase-3 is involved in the execution of apoptosis and
is cleaved into an active form upon apoptotic stimuli
(Nicholson and Thornberry, 1997). We examined levels of
caspase-3 cleavage in the presence or absence of treatment
with U0126. Before stretch, there was very little cleavage of
caspase-3 in either cell line (Figure 8a, i). The antibody used
here recognizes the p17 fragment of cleaved caspase-3,
hence the appearance of only one band.
In both cell lines, caspase-3 cleavage increases after
stretch and during recovery from stretch, although levels in
KEB-7 are lower than in NEB-1 cells. U0126 treatment has no
significant effect on caspase-3 cleavage in NEB-1 cells, but at
24 and 48 hours recovery from stretch, U0126 significantly
increases caspase-3 cleavage in KEB-7 cells (Figure 8a, i). To
examine whether the increase in caspase-3 cleavage in
response to U0126 treatment in KEB-7 cells leads to an
increase in apoptosis, cells were treated with 5mM U0126 and
subjected to mechanical stretch as before (Figure 8b). As was
shown previously (Figure 1), before stretch both cell lines
exhibit similar low numbers of apoptotic cells. In response to
stretch and during recovery from stretch, U0126 treatment
increases apoptotic cell numbers in KEB-7 cells and the
apoptosis profile is more similar to that of wild-type NEB-1
cells than in the absence of U0126 (compare graphs in
Figures 1 and 8b). These results show that treating KEB-7 cells
with U0126 results in increased apoptosis in response to
stretch and drives the apoptotic response of these mutant
cells back toward that of the wild-type cells.
siRNA knockdown of mutant K14 increases stretch-induced
apoptosis in KEB-7 cells
As NEB-1 and KEB-7 are immortalized cells, it is possible that
the differences in apoptosis were due to other genetic
changes rather than the keratin mutation itself. To determine
whether the K14-R125P mutation is specifically responsible
for the reduced apoptosis in KEB-7 cells, we treated them
with a mutation-specific small interfering RNA (siRNA)
(Figure 9). A drop in keratin 14 levels was found 24 hours
after transfection but was maximal 120 hours post-transfec-
tion. At this time, K14 levels were 52% of that of untreated
cells, in keeping with translation being curtailed from the
mutant allele. Mutation-specific siRNA had no effect on K14
levels in NEB-1 cells (results not shown). Mock transfection or
transfection with nonspecific GL2 siRNA also had no effect
on K14 levels in KEB-7 cells (Figure 9a and b).
KEB-7 cells treated with mutation-specific siRNA show
similar low levels of apoptosis to untreated cells, indicating
that siRNA treatment per se does not induce apoptosis in
these cells. As shown previously (Figure 1), oscillating stretch
leads to more apoptosis during recovery than in unstretched
cells, although less so in mutant cells than wild-type.
However, pretreating KEB-7 cells with mutation-specific
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Figure 7. ERK signaling in DM-EBS (KEB-7) cells is insensitive to serum
removal but sensitive to U0126 treatment. Cells were incubated for 2 hours
in the presence or absence of serum in parallel with the presence or absence
of 5mM U0126. Cell lysates were prepared and 10mg lysate was separated
by SDS–PAGE and immunoblotted with antibodies against phosphor-p42/44
MAPK (a), phospho-p90RSK (b), and p90RSK (c).
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siRNA to downregulate the mutant K14 significantly raised
the incidence of apoptosis (Figure 9c). This suggests that the
reduced stretch-induced apoptosis in KEB-7 cells is specifi-
cally due to the presence of the mutant K14.
We tested whether the restored apoptosis profile described
above was associated with changes in signaling events and
examined ERK and Akt phosphorylation. Cells were treated
with K14-R125P siRNA and subjected to stretch/recovery as
before. As shown previously (Figure 3), KEB-7 cells have
increased p42/44 (ERK) phosphorylation compared with
wild-type cells (Figure 9d). In both cell lines, siRNA treatment
reduced ERK phosphorylation, although this was still
increased in KEB-7 cells (Figure 9d). These data suggest that
the removal of the mutant keratin is alleviating the need for
the survival signal derived from ERK leading to increased
apoptosis. This is supported by our observation that removing
the survival signal by inhibiting ERK signaling also leads to
increased apoptosis in KEB-7 cells in response to stretch
(Figure 7). SiRNA treatment also reduced Akt-Thr308
phosphorylation in KEB-7 cells but increases Akt-Ser473
phosphorylation (Figure 9d). Our data support a role for ERK
in the suppression of apoptosis in cells harboring a keratin
mutation but suggest that Akt signaling may also have a role.
This is supported by data showing that Akt activation by
mechanical stretch generates antiapoptotic signals in human
keratinocytes (Yano et al., 2004, 2006).
DISCUSSION
In this study we have shown that cells carrying a severe EBS
keratin mutation are protected from stretch-induced apopto-
sis by a process that involves increased signaling from the
ERK pathway. The specific involvement of the ERK pathway
in the increased cell survival is confirmed by the loss of
apoptosis resistance after U0126 treatment, and the specific
dependence on the mutant keratin is shown by the loss of
apoptosis resistance upon knockdown of the mutant K14
allele with mutation-specific siRNA. It is likely that Akt also
has a role and the involvement of this and the ERK pathway in
promoting cell survival by generating antiapoptotic signals is
well documented (Bonni et al., 1999; Parcellier et al., 2008).
However, increased ERK signaling due to the presence of a
pathogenic keratin mutation is a previously unidentified
observation.
Severe DM EBS, of the kind studied here, is accompanied
by the appearance of hallmark protein aggregates in the
fragile basal keratinocytes, raising the possibility of a
misfolded protein response being activated in these cells.
As the causes of increasing numbers of monogenic diseases
are identified, a recurrent emerging theme is the accumula-
tion of misfolded protein, often in excess of the capacity of
the cell’s internal clearance mechanism, and the burden this
can place on the physiology of the cell. Pathological
aggregates of intermediate filaments and other proteins are
seen in neurofibrillary tangles of neurodegenerative disorders
(Agorogiannis et al., 2004). Desmin aggregates are observed
in several myopathies (Selcen, 2008), and keratin aggregates
are characteristic of severe EBS (Kitajima et al., 1989).
Keratin aggregates can also form under normal circum-
stances, in association with hyperphosphorylation at mitosis
(Lane et al., 1982; Chou et al., 1989; Nigg, 1992; Goto et al.,
2000). Increased phosphorylation is associated with inter-
mediate filament remodeling and aggregate formation during
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Figure 8. U0126 treatment increases apoptosis in response to stretch
in DM-EBS (KEB-7) keratinocytes. Control (NEB-1) and DM-EBS (KEB-7)
cells were subjected to mechanical stretch in the presence or absence of
5mM U0126. Cell lysates were prepared and 10mg lysate was separated by
SDS–PAGE and immunoblotted with antibodies against cleaved Caspase-3
(Asp175) (a, i), or GAPDH (a, ii). Lysates were examined prior to stretch
(0 hours), after 2 hours of stretch (2 hours), and at 24 and 48 hours recovery
from 2hours of stretch. During the recovery phase (24 and 48 hours), cells
were dosed with fresh U0126 every 8 hours. Band intensities are shown
graphically from three independent experiments. Blots shown are
representative, and error bars represent s.d. Cells were also examined for the
effect of U0126 treatment on numbers of apoptotic cells (b). Cells were 4,6-
diamidino-2-phenylindole stained, and 100 cells were counted and scored for
the appearance of apoptotic nuclei. This was repeated three times, and the
average percentage of apoptotic cells was plotted. Error bars represent SD.
NS, no stretch; Rec, recovery; Str, stretch.
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mitosis (Goto et al., 2002, 2003) and a link between
increased phosphorylation and aggregate formation has been
demonstrated for vimentin intermediate filaments (Chou
et al., 1990, 1996; Perng et al., 1994) and keratins (Eckert
and Yeagle, 1990; Negron and Eckert, 2000). However, in
the case of diseases, mechanisms involving recognition of
misfolded protein and stalled proteasome function are
suspected. The two processes may also be interlinked, as
the remodeling by phosphorylation/dephosphorylation events
means that intermediate filament proteins are themselves
potential mediators of stress-induced signaling in vivo.
Evidence from several different sources now suggests that
intermediate filaments have a more direct role in many
processes associated with cell stress (reviewed by Owens and
Lane, 2004; Pekny and Lane, 2007).
In attempts to model the disease process of EBS, we were
recently able to show that when cells expressing a DM-EBS-
associated mutation are subjected to oscillating mechanical
stretch in tissue culture, they undergo dramatic changes in
keratin configuration involving breakdown of filaments,
increased formation of keratin aggregates, and a concurrent
redistribution of cell junction proteins (Russell et al., 2004). In
this study we have now analyzed some of the molecular
consequences of mechanical stress for cells whose resilience
is weakened by pathogenic mutations. We demonstrate that
keratinocytes from a DM-EBS patient (mutation K14 R125P,
Morley et al., 2003) show constitutively elevated phosphor-
ylation of ERK pathway components, which are activated
further in response to mechanical stretching. This increased
ERK activity is associated with a lowered apoptosis rate than
in wild-type cells when the cells are subjected to mechanical
stress. The reduced apoptotic rate in DM-EBS cells can be
raised again by blocking the function of ERK with the specific
inhibitor U0126, or by preventing mutant keratin synthesis
with mutation-specific interfering RNA, demonstrating that
the effect involves the ERK and Akt pathways and is a specific
consequence of the presence of the keratin mutation. From
our results, the role of the ERK pathway in reducing apoptosis
appears more clearly defined. Our data also suggest that
the Akt pathway is likely to be involved, but not enough
mechanistic data are presented to address its role here.
Our results suggest that although the presence of mutant
keratin leads to a constitutively activated ERK kinase
signaling pathway, one outcome of this is to suppress
apoptotic signaling by switching on survival signals, in a
type of misfolded protein response. A role for intermediate
filaments in reducing apoptosis has been demonstrated by
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Figure 9. K14-R125P-specific small interfering RNA (siRNA) increases
apoptosis in DM-EBS (KEB-7) keratinocytes. The DM-EBS (KEB-7) cell line
carries the severely disruptive keratin mutation K14-R125P. A K14-R125P-
specific siRNA was designed and cells were transfected with the siRNA.
(a) Keratin 5 and 14 levels were examined using immunoblotting to determine
the effect of siRNA treatment. Cells were untreated, mock transfected,
transfected with mutation-specific siRNAs, and transfected with the control
siRNA against the Photinus pyralis luciferase gene GL2. The greatest drop
in keratin 14 levels was observed after 120 hours. Keratin 14 expression
at this time point was 52% (b). Lower expression would not be expected,
as this is a heterozygous mutation. KEB-7 cells treated with the K14-R125P
siRNA were examined for apoptosis. Cells were treated with the
mutation-specific siRNA for 96 hours. Cells were then stretched and then
4,6-diamidino-2-phenylindole stained and 100 cells counted and scored
for the appearance of apoptotic nuclei. This was repeated three times and
the average percentage of apoptotic cells was plotted (c). It was observed
that apoptosis was significantly increased in the siRNA-treated cells and
the numbers of apoptotic cells were similar to those found previously for
wild-type (NEB-1) cells. Error bars represent s.d. (Rec, recovery; Str, Stretch).
(d) Cell lysates were probed for Akt and ERK phosphorylation. NEB-1 (lane 3)
and KEB-7 (lane 4) were treated with K14-R125P-specific siRNA for 96 hours,
then subjected to two hours stretch, and 48 hours recovery from stretch.
Untreated and treated NEB-1 (lane 1) and KEB-7 (lane 2) were used as
controls. siRNA treatment reduces phosphorylation of Akt-Thr308 and
ERK but increases phosphorylation of Akt at serine 473.
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data showing that vimentin binds to phosphorylated ERK and
prevents its dephosphorylation, thus suppressing apoptosis
(Perlson et al., 2006). Some cells in culture express vimentin,
but the cells used here do not and this mechanism cannot be
responsible for the reduced apoptosis observed in the
presence of the K14-R125P mutation.
Many pathways are likely to be involved in signaling the
presence of mutated proteins within cells, and responses are
probably numerous depending on how the mutant protein
alters cellular processes. One can imagine the benefit of
inducing apoptosis in the presence of a sudden increase in
protein levels within cells. Yoneda et al. (2004) showed that
in response to transient transfection of mutant keratin into
keratinocytes, a feedback loop exists that induces apoptosis
by tumor necrosis factor-a signaling. We have not examined
tumor necrosis factor-a signaling in this work, but our results
may represent the situation where cells have mounted an
adaptive response that involves ERK (and less clearly defined
Akt) signaling to allow cells to survive the chronic, rather than
sudden, presence of mutated keratin.
The reduced apoptosis described here in severe EBS raises
the obvious question of whether there is an increased cancer
risk among DM-EBS sufferers. This appears to be so, according
to a recent analysis that showed that the cumulative risk of
DM-EBS individuals developing basal-cell carcinoma is 43.6%
by age 55 years (Fine et al., 2009).
This analysis of the chronic stress signaling resulting from
continued expression of the mutant protein could provide an
insight into the increased incidence of basal-cell carcinoma
in DM-EBS patients. This work also highlights the need for
analysis of components of the pathways responding to the
presence of mutant structural proteins in cells as this may
suggest new, generic and more easily applicable strategies for
treatment of genetic disorders.
MATERIALS AND METHODS
Cell culture
The patient-derived keratinocyte cell lines used in this study have
been previously characterized (Morley et al., 2003). The KEB-7
keratinocyte line was derived from an individual carrying an R125P
mutation in the K14 1A domain; this is the strongest mutation
hotspot for keratins, which, in K14, is associated with a severe DM-
EBS phenotype (http://www.interfil.org). NEB-1 cells were derived
from an unaffected individual. Both cell lines were immortalized
using HPV16 (E6^E7).
NEB-1 and KEB-7 cells were cultured in 75% DMEM plus 25%
Ham’s F12 medium, adding 10% fetal calf serum and additional
growth factors hydrocortisone (0.4 mgml1), transferrin (5 mgml1),
lyothyronine (2 1011 M), adenine (1.9 104 M) and insulin
(5mgml1). These cell lines are fibroblast feeder cell independent
and were cultured at 37 1C in 5% CO2. Fetal calf serum was omitted
from culture medium for cells to be cultured in the absence of serum.
HaCaT cells were cultured in DMEM supplemented with 10% fetal
calf serum and cultured at 37 1C in 5% CO2.
Mechanical stretch
Cells were subjected to mechanical stress by stretching a deformable
substrate on which they were grown. Stretching was carried out using
FX-4000T Cell Stretcher (Flexcell International, Hillsborough, NC).
Six-well Flexplates (Flexcell International) were coated with collagen
IV (Sigma-Aldrich, Dorset, UK) at a concentration of 20mgml1 for
60minutes at room temperature and then incubated for 60minutes
with 5% BSA in DMEM supplemented with 10% fetal calf serum.
Cells were seeded onto the Flexplates and grown to 80% conflu-
ence. Stretch was carried out at a frequency of 4Hz and an actual
amplitude of 12% for times varying up to 180minutes, at 37 1C in
5% CO2. Cells were then harvested or prepared for microscopy.
Wells in flexplates not being stretched were isolated from the vacuum
source using FlexStops (Flexcell International). At appropriate times,
FlexStops were removed and stretching was resumed in the well.
Immunoprecipitation
A volume of 20ml of protein-G beads (Cancer Research UK, London)
were washed twice in phosphate buffered saline (PBS). Between each
wash the beads were centrifuged for 30 seconds in an Eppendorf 5415D
microfuge (Eppendorf, Cambridge, UK) at maximum speed. The mAbs
against BAD (1:50 dilution, Cell Signaling Technology, Hertfordshire,
UK) and glyceraldehyde-3-phosphate dehydrogenase (1:250 dilution,
Abcam, Cambridge, UK) were bound to beads for 1–2hours at 4 1C with
gentle agitation. After incubation with antibodies, beads were washed
twice with PBS as before. This was followed by washing twice with
MEBC lysis buffer (50mM Tris pH 7.4, 100mM NaCl, 0.5% NP40,
5mM EGTA, 5mM EDTA, 40mM b-glycerol phosphate). Cells from
10cm tissue culture plates were lysed using 100ml MEBC lysis buffer
and cells from Flexplates were lysed using 50ml MEBC lysis buffer,
and added to prelabelled 1.5ml microfuge tubes. In each tube the
final volume was made up to 500ml with MEBC buffer and the
lysate was incubated with 20ml of antibody-coated beads for 2–4hours
at 4 1C with gentle agitation. Beads were then washed four times with
MEBC buffer as before. To each sample, 50ml of double strength
sample buffer was added. Samples were boiled for 10minutes and
then centrifuged briefly. Samples were separated by SDS–PAGE and
transferred to nitrocellulose membrane and examined by immuno-
blotting. All antibodies used for immunoblotting are listed below.
Immunoblotting
Cells were kept on ice and washed twice with ice-cold PBS. Lysis
buffer, containing 100mM Tris (pH 7.4), 50mM b-glycerol phosphate,
0.5mM Na3VO4, 1mM ethyleneglycol-bis (b-aminoethyl ether)-N,
N, N0, N0-tetracetic acid, 1% Triton X-100, 1mM microcystin (Sigma,
Dorset, UK), and one complete (EDTA-free) protease inhibitor
cocktail tablet (Roche, Welwyn Garden City, UK) per 50ml lysis
buffer, was added and left for 5minutes. Cells were then harvested
and centrifuged at 14,000 r.p.m. for 10minutes at 4 1C. Supernatant
was then decanted and protein concentration was determined by
the method of Bradford, and standardized using BSA.
For SDS–PAGE, 10mg of protein was prepared in SDS sample buffer
(4% SDS, 20% glycerol, 20mM Tris-HCl (pH 6.8), 20mM dithiothreitol,
1% bromophenol blue). Samples were then boiled for 5minutes and
separated on SDS gels. For immunoblotting, proteins were transferred
onto nitrocellulose membrane at 300mA for 60minutes. Nonspecific
binding to membranes was blocked by soaking in Tris-buffered saline
(pH 7.6) containing 0.5% TWEEN-20 and 5% fat-free milk powder
for 60minutes at room temperature with gentle agitation. Membranes
were then incubated overnight at 4 1C with gentle agitation in pri-
mary antibodies anti-MEK1/2, anti-phospho-MEK1/2 (serine 217/221),
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anti-phospho-ERK1/2 (threonine 202/tyrosine 204), anti-phospho-
p90RSK (serine 381), anti-Akt, anti-phospho-Akt (threonine 308),
anti-phospho-Akt (serine 473), anti-BAD, anti-phospho-BAD (serine
112), anti-phospho-BAD (serine 136), anti-phospho-BAD (serine 155),
anti-BcL-XL (all polyclonal antibodies from Cell Signaling Techno-
logy), polyclonal antibodies anti-PKA, anti-phospho-PKA (serine 96),
anti-PP2B (all from Millipore, Coatford, UK) and anti-14-3-3 (ab9063,
Abcam), anti-keratin 5 (BL-18; Purkis et al., 1990)) or the mouse
mAbs anti-glyceraldehyde-3-phosphate dehydrogenase (ab8245,
Abcam), anti-keratin 14 (LL001, Purkis et al., 1990); rabbit mono-
clonals caspase-3 (8G10) and cleaved caspase-3 (Asp175) (5A1)
(Cell Signaling Technology). All primary antibodies were used at a
dilution 1:1,000 in TBS/3% BSA. Membranes were then washed
3 15minutes in 1% TBS-Tween 20, and bound polyclonal primary
and rabbit mAbs were detected using a swine anti-rabbit Ig anti-
serum secondary antibody (diluted 1:2,000 in blocking buffer).
Glyceraldehyde-3-phosphate dehydrogenase was detected using a
rabbit anti-mouse IgG antibody (diluted 1:2,000 in blocking buffer).
The secondary antibodies were conjugated to horseradish peroxidase
and visualized using ECL (Amersham Pharmacia, Buckinghamshire,
UK). Band intensities from immunoblots were measured using a
GS-800 Calibrated Densitometer (Bio-Rad, Herlev, Denmark).
siRNA design
Small interfering RNAs targeting K14 were designed relative to the open
reading frame at position 47–1,465 of the K14 mRNA sequence using
EditSeq from DNAstar software (version 5.07 for Power Macintosh,
Madison, WI). The siRNAs were purchased from Dharmacon Research
(La Fayette, CO) and prepared according to the manufacturer’s
instructions. siRNA sequences were designed as follows: K14-R125P
(mutation-specific against K14R125P using sequence position 367–389
relative to open reading frame (50-UGACCCCCUGGCCUCCUACCU-
dTdT)) and GL2 (control siRNA sequence targeting the Photinus pyralis
luciferase gene GL2 (50-CGUACGCGGAAUACUUCGA-dTdT)).
siRNA treatment
Before 24hours transfection, cells were plated into 6cm tissue culture
dishes (Nunclon surface, Nunc, distributed by VWR International,
Lutterworth, Leicestershire, UK) for experiments to check the knock-
down of K14 or cells were plated onto six-well Flexplates (see
mechanical stretch method). On the day of transfection, 1.5ml micro-
fuge tubes (Eppendorf) were prepared for each dish or well to be
transfected. Into each tube, 500ml OPTIMEM 1 media (Gibco,
Invitrogen, Paisley, UK), 10ml Mirus Transit-TKO reagent (Dharmacon)
was added. The mixture was vortexed briefly and then incubated at
room temperature for 5minutes. SiRNA was added to the OPTIMEM 1/
Mirus-TKO mixture to give a final siRNA concentration of 1ngml1 for
the single transfections (K14-R125P and GL2) to give a final siRNA
concentration of 0.33ngml1 of each. The solution was mixed by
gentle pipetting and incubated for 20minutes at room temperature
and then added to cells. The cells were harvested at 24, 48, 72, 96,
and 120hours post-transfection using the method described in the
immunoblotting method. Stretch experiments were carried out on
cells 96hours post-transfection.
Apoptosis detection
After U0126 treatment and/or stretching, culture medium was removed
and transferred to a 15ml tube to collect any detached cells. Adherent
cells were trypsinized and resuspended in fresh culture medium.
Detached cells were added to trypsinized cell suspension and
centrifuged at 1,000 r.p.m. for 5minutes at 4 1C. The supernatant was
discarded and the pelleted cells resuspended in 1ml cold methanol/
acetone (1:1). Cells were pelleted as before and washed twice with
cold PBS. Finally, the pellet was resuspended in 1ml PBS containing
4,6-diamidino-2-phenylindole at a dilution of 1:1,000. A volume of
500ml of cell suspension was gently mixed with CitiFluor (Sigma-
Aldrich) and placed on a glass slide and covered with a coverslip
and allowed to dry. Six fields of view were selected at random and
an image was collected using an Axiovert 200M system (Carl Zeiss,
Welwyn Garden City, UK). A total of 100 cells were selected at
random and scored for apoptotic figures (mitotic cells or recently
divided cells were ignored). This was repeated three times
and average number of apoptotic cells per 100 cells was plotted.
Drug treatment
Cells were treated with 5mM of the MEK1/2 inhibitor U0126 (Cell
Signaling Technology), or 10mM of Etoposide (Sigma-Aldrich) for
varying times. Both were prepared in prewarmed cell culture medium.
Transfection
For liposome-based transfection three  104 keratinocytes were
seeded onto 22mm2 sterile coverslips and cultured until approxi-
mately 60–70% confluent (approximately 1 105 cells). For electro-
poration transfection, a trypsinized cell solution was diluted in
prewarmed culture medium to give 1 105 cells per transformation.
A quantity of 2 mg of DNA was used for each transfection for both
liposome and electroporation transfection. Liposomal transfection
was carried out using Lipofectamine 2000 (Gibco BRL Life
Technologies, Paisley, UK) as per the manufacturer’s instructions.
Electroporation was carried out using a Nucleofactor Device
(Amaxa Biosystems, Cologne, Germany). Transfection was carried
out using the program U-20 and Nucleofactor Kit V (Amaxa
Biosystems) as per the manufacturer’s instructions. Cells were
transfected with K5, K14 R125P, or tubulin. These were expressed
from the pEGFP-C1 construct (Clontech, Hampshire, UK). An empty
pEGFP-C1 construct was used as a control and mock transfections
were also carried out.
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